Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially ...

Behavioral variability is quietly sabotaging clinical trials—but it doesn't have to. Here's how predictive behavioral modeling can improve trial design, reduce dropout, and deliver more inclusive, ...

These analyses enable a broader, more inclusive approach to care that helps staff optimize processes not just for the most obvious cases but for the entire patient population, explains a nurse deeply ...

ProofPilot, the leading end-to-end clinical experience platform, today announced the acquisition of Lokavant, the clinical trial intelligence company and the premier provider of predictive analytics ...

AI-enabled analytics are transforming healthcare from static data to real-time insights. A driving force behind this shift, Kiran Veernapu is modernizing systems to improve patient outcomes and ...

Sight Sciences (Nasdaq:SGHT) today announced new clinical data supporting its Omni minimally invasive glaucoma surgery (MIGS) device.

Our understanding of the molecular pathogenesis of LAMA2 -related muscular dystrophy ( LAMA2 -MD) requires improving. Here, we report the phenotype, neuropathology, and transcriptomics data (scRNA-seq ...

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...

Generative artificial intelligence (AI) has absolutely exploded onto the scene. It's become a top strategic priority in the ...

The reliance of the pharmaceutical industry on data is fairly high for planning clinical trials, managing resources, and bringing new drugs to market. Yet one of its biggest challenges remains the ...

As value-based care (VBC) continues to redefine reimbursement models and quality standards in skilled nursing facilities ...